Approvals/CIMA-AEMPS/OXALIPLATINO HIKMA 5 MG/ML CONCENTRADO PARA SOLUCION PARA PERFUSION EFG

Approved

STANDARD

OXALIPLATINO HIKMA 5 MG/ML CONCENTRADO PARA SOLUCION PARA PERFUSION EFG

Hikma Farmaceutica (Portugal) S.A.🇪🇸 Spanish Agency of Medicines and Medical Devices

Approval Id: 4d6d6aeda90b122e
Drug Cima Aemps Name: OXALIPLATINO HIKMA 5 MG/ML CONCENTRADO PARA SOLUCION PARA PERFUSION EFG
Register Number: 86380
Holder Company Name: Hikma Farmaceutica (Portugal) S.A.
Marketing Company Name: Hikma España, S.L.U.
Holder Company Detail Path: /organization/hikma-farmaceutica-portugal-s-a
Authorization Date: 2021-11-11
Dosage Form: CONCENTRADO PARA SOLUCIÓN PARA PERFUSIÓN
Dose: 5 mg/ml
Route Of Administration: VÍA INTRAVENOSA
Prescription Type: Uso Hospitalario
Commercialized: Yes
Company Name: Hikma Farmaceutica (Portugal) S.A.
Company Detail Path: /organization/hikma-farmaceutica-portugal-s-a

OXALIPLATINO

5 mg/ml

Approved

Agency

CIMA-AEMPS

Country

🇪🇸

Approval Date

Nov 11, 2021

Approval ID

4d6d6aeda90b122e

Type

Standard